RDP Pharma AG
RDP Pharma AG is a privately held biotech and seed investor based in Romanshorn, Switzerland. Our core team has a highly successful, proven track record of bringing new medications to the market, particularly in the field of oncology. We identify new therapeutic modalities to create breakthrough medicines, specifically through our rationally designed, targeted protein degradation platform PROMPTDegrader (PRoteasomal Oral Monovalent Protein Targeting).
Date, time and room information
May 6, 13:15 - 13:30, room Montreal
Category
Clinical stage development company
Title of the presentation
Rationally Designed Targeted Protein Degradation of Intrinsically Disordered Regions
Speaker information
| Name | Position | Institution |
|---|---|---|
| Dr. Michael Ahrweiler | Chief Development Officer | RDP Pharma AG |
